Literature DB >> 33566963

Assessment of Peripheral Blood Mononuclear Cells Senescence and Endothelial Dysfunction among Adults with High Cardiovascular Risk.

Vijay Raj1, Soniya Charles2, Luxitaa Goenka3, Thilagavathi Ramamoorthy4, Marimuthu C5, Emmanuel C5, Kanchana Mala1, Subramaniyan Kumarasamy6, Melvin George3.   

Abstract

BACKGROUND: Cardiovascular diseases (CVD) are one of the leading causes of mortality and morbidity worldwide. Biological aging has been associated with the occurrence of adverse cardiovascular outcomes; however, the underlying mechanism of this process remains unknown.
OBJECTIVES: This study sought to evaluate if peripheral blood mononuclear cell (PBMC) senescence and endothelial biomarkers could influence cardiovascular (CV) risk and be suitable markers for the early detection of cardiovascular diseases in adults.
METHODS: In this cross-sectional study patients free of CVD were classified as lower (n=32) and higher Interheart Risk (IHR) scores (n=28). PBMC senescence was assessed by estimating the telomerase activity (TA) and detecting the presence of senescent cells and endothelial dysfunction by estimating the concentration of nitrite and nitrate and of total antioxidant capacity (TAC). Statistical analysis was performed with SPSS version 16.0 (SPSS Inc., Chicago, IL). All p-values <0.05 were considered statistically significant.
RESULTS: PBMC senescence 0.95 [p-value = 0.0001; 95% CI (0.874-1.026)] was a significant predictor of patients with higher IHR scores with a cut-off value of 21.65 with a sensitivity and specificity of 92% and 88% respectively. PBMC senescence, nitrite and nitrate and TA were found to be independently associated with high IHR scores.
CONCLUSION: PBMC senescence, TA and nitrite, and nitrate status are suitable measures to predict high cardiovascular risk in adults with CV risk. Nevertheless, long-term follow-up studies are needed to confirm these findings. (Arq Bras Cardiol. 2021; 116(1):37-47).

Entities:  

Mesh:

Year:  2021        PMID: 33566963      PMCID: PMC8159491          DOI: 10.36660/abc.20190409

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  30 in total

Review 1.  Telomere biology and cardiovascular disease.

Authors:  José J Fuster; Vicente Andrés
Journal:  Circ Res       Date:  2006-11-24       Impact factor: 17.367

2.  White cell telomere length and risk of premature myocardial infarction.

Authors:  Scott Brouilette; Ravi K Singh; John R Thompson; Alison H Goodall; Nilesh J Samani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-20       Impact factor: 8.311

Review 3.  Senescent cells: a therapeutic target for cardiovascular disease.

Authors:  Bennett G Childs; Hu Li; Jan M van Deursen
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

4.  Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals.

Authors:  Alexander Scheller Madrid; Line Rode; Børge G Nordestgaard; Stig E Bojesen
Journal:  Clin Chem       Date:  2016-06-03       Impact factor: 8.327

5.  Cardiovascular Disease Risk Assessment: Insights from Framingham.

Authors:  Ralph B D'Agostino; Michael J Pencina; Joseph M Massaro; Sean Coady
Journal:  Glob Heart       Date:  2013-03

Review 6.  Mechanical factors in arterial aging: a clinical perspective.

Authors:  Michael F O'Rourke; Junichiro Hashimoto
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094

7.  Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.

Authors:  Maria Del Ben; Mario Fabiani; Lorenzo Loffredo; Licia Polimeni; Roberto Carnevale; Francesco Baratta; Marco Brunori; Fabiana Albanese; Teresa Augelletti; Francesco Violi; Francesco Angelico
Journal:  BMC Pulm Med       Date:  2012-07-23       Impact factor: 3.317

Review 8.  The role of oxidative stress and inflammation in cardiovascular aging.

Authors:  Junzhen Wu; Shijin Xia; Bill Kalionis; Wenbin Wan; Tao Sun
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

9.  Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases.

Authors:  Irina D Strazhesko; Olga N Tkacheva; Dariga U Akasheva; Ekaterina N Dudinskaya; Ekaterina V Plokhova; Valentina S Pykhtina; Anna S Kruglikova; Natalia V Kokshagina; Natalia V Sharashkina; Mikhail V Agaltsov; Daria A Kashtanova; Vladimir A Vygodin; Irina N Ozerova; Dmitry A Skvortsov; Daria Vasilkova; Sergey A Boytsov
Journal:  Front Pharmacol       Date:  2016-09-30       Impact factor: 5.810

10.  Cardiovascular Disease Risk Assessment in the United States and Low- and Middle-Income Countries Using Predicted Heart/Vascular Age.

Authors:  Duke Appiah; Benjamin D Capistrant
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.